Skip to content

Released Aug 6, 2020, before the open

10-Q filed Aug 6, 2020, 37 days after period end · 0001564590-20-037284

Q2 2020 · 10-Q
Revenue$73.14M−36.9% vs Q2 2019−30.2% vs Q1 2020
Net Income-$18.42MN/M vs Q2 2019N/M vs Q1 2020
EPS Diluted-$0.96N/M vs Q2 2019N/M vs Q1 2020
Gross Profit$49,969,000−44.5%
Operating Income-$21,000,000N/M
Operating Cash Flowderived$17,630,000+87.9%
Free Cash Flowderived$13,355,000+201.4%
Margins · derived
Gross margin68.3%−9.4 pt vs Q2 2019
Operating margin-28.7%−29.1 pt vs Q2 2019
Net margin-25.2%−24.7 pt vs Q2 2019

What the release said

The release

Same quarter

MetricQ2 2020Q2 2019Q2 2018Q2 2017
Revenue$73.14M$115.85M$111.55M$108.94M
Net Income-$18.42M-$547.00K$925.00K$3.85M
EPS Diluted-$0.96-$0.03$0.05$0.21

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR